Substrate specificity of Saccharomyces cerevisiae myristoyl-CoA: protein N-myristoyltransferase. Analysis of fatty acid analogs containing carbonyl groups, nitrogen heteroatoms, and nitrogen heterocycles in an in vitro enzyme assay and subsequent identification of inhibitors of human immunodeficiency virus I replication
- PMID: 1559967
Substrate specificity of Saccharomyces cerevisiae myristoyl-CoA: protein N-myristoyltransferase. Analysis of fatty acid analogs containing carbonyl groups, nitrogen heteroatoms, and nitrogen heterocycles in an in vitro enzyme assay and subsequent identification of inhibitors of human immunodeficiency virus I replication
Abstract
Covalent attachment of myristic acid (C14:0) to the amino-terminal glycine residue of a variety of eukaryotic cellular and viral proteins can have a profound influence on their biological properties. The enzyme that catalyzes this modification, myristoyl-CoA-protein N-myristoyltransferase (NMT), has been identified as a potential target for antiviral and antifungal therapy. Its reaction mechanism is ordered Bi Bi with myristoyl-CoA binding occurring before binding of peptide and CoA release preceding release of myristoylpeptide. Perturbations in the binding of its acyl-CoA substrate would therefore be expected to have an important influence on catalysis. We have synthesized 56 analogs of myristic acid (C14:0) to further characterize the acyl-CoA binding site of Saccharomyces cerevisiae NMT. The activity of fatty acid analogs was assessed using a coupled in vitro assay system that employed the reportedly nonspecific Pseudomonas acyl-CoA synthetase, purified S. cerevisiae NMT, and octapeptide substrates derived from residues 2-9 of the catalytic subunit of cyclic AMP-dependent protein kinase and the Pr55gag polyprotein precursor of human immunodeficiency virus I (HIV-I). Analysis of ketocarbonyl-, ester-, and amide-containing myristic acid analogs (the latter in two isomeric arrangements, the acylamino acid (-CO-NH-) and the amide (-NH-CO)) indicated that the enzyme's binding site is able to accommodate a dipolar protrusion from C4 through C13. This includes the region of the acyl chain occurring near C5-C6 (numbered from carboxyl) that appears to be bound in a bent conformation of 140-150 degrees. The activities of NMT's acyl-CoA substrates decrease with increasing polarity. This relationship was particularly apparent from an analysis of a series of analogs in which the hydrocarbon chain was terminated by (i) an azido group or (ii) one of three nitrogen heterocycles (imidazole, triazole, and tetrazole) alkylated at either nitrogen or carbon. This inverse relationship between polarity and activity was confirmed after comparison of the activities of the closely related ester- or amide-containing tetradecanoyl-CoA derivatives. Members from all of the analog series were surveyed to determine whether they could inhibit replication of human immunodeficiency virus I (HIV-I), a retrovirus that depends upon N-myristoylation of its Pr55gag for propagation. 12-Azidododecanoic acid was the most active analog tested, producing a 60-90% inhibition of viral production in both acutely and chronically infected T-lymphocyte cell lines at a concentration of 10-50 microM without associated cellular toxicity.
Similar articles
-
The substrate specificity of Saccharomyces cerevisiae myristoyl-CoA: protein N-myristoyltransferase. Polar probes of the enzyme's myristoyl-CoA recognition site.J Biol Chem. 1994 Feb 18;269(7):5346-57. J Biol Chem. 1994. PMID: 8106519
-
The substrate specificity of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. Analysis of myristic acid analogs containing oxygen, sulfur, double bonds, triple bonds, and/or an aromatic residue.J Biol Chem. 1991 May 15;266(14):8835-55. J Biol Chem. 1991. PMID: 2026598
-
Comparison of the acyl chain specificities of human myristoyl-CoA synthetase and human myristoyl-CoA:protein N-myristoyltransferase.J Biol Chem. 1993 Mar 5;268(7):4889-902. J Biol Chem. 1993. PMID: 8444867
-
The structure of myristoyl-CoA:protein N-myristoyltransferase.Biochim Biophys Acta. 1999 Nov 23;1441(2-3):162-72. doi: 10.1016/s1388-1981(99)00155-9. Biochim Biophys Acta. 1999. PMID: 10570244 Review.
-
MyristoylCoA:protein N-myristoyltransferase.Adv Enzymol Relat Areas Mol Biol. 1993;67:375-430. doi: 10.1002/9780470123133.ch5. Adv Enzymol Relat Areas Mol Biol. 1993. PMID: 8322618 Review. No abstract available.
Cited by
-
Targeting human immunodeficiency virus type 1 assembly, maturation and budding.Drug Target Insights. 2007;2:159-82. Epub 2007 Jul 20. Drug Target Insights. 2007. PMID: 21901072 Free PMC article.
-
Recent progress in enzymatic protein labelling techniques and their applications.Chem Soc Rev. 2018 Dec 21;47(24):9106-9136. doi: 10.1039/c8cs00537k. Epub 2018 Sep 27. Chem Soc Rev. 2018. PMID: 30259933 Free PMC article. Review.
-
N-Myristoyltransferase isozymes exhibit differential specificity for human immunodeficiency virus type 1 Gag and Nef.J Gen Virol. 2008 Jan;89(Pt 1):288-296. doi: 10.1099/vir.0.83412-0. J Gen Virol. 2008. PMID: 18089753 Free PMC article.
-
Exploiting Protein N-Terminus for Site-Specific Bioconjugation.Molecules. 2021 Jun 9;26(12):3521. doi: 10.3390/molecules26123521. Molecules. 2021. PMID: 34207845 Free PMC article. Review.
-
Genetically Encoded Photocleavable Linkers for Patterned Protein Release from Biomaterials.J Am Chem Soc. 2019 Oct 2;141(39):15619-15625. doi: 10.1021/jacs.9b07239. Epub 2019 Sep 17. J Am Chem Soc. 2019. PMID: 31525979 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous